全文获取类型
收费全文 | 617篇 |
免费 | 58篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 20篇 |
妇产科学 | 8篇 |
基础医学 | 50篇 |
口腔科学 | 44篇 |
临床医学 | 39篇 |
内科学 | 91篇 |
皮肤病学 | 20篇 |
神经病学 | 6篇 |
特种医学 | 94篇 |
外科学 | 170篇 |
综合类 | 29篇 |
预防医学 | 18篇 |
眼科学 | 7篇 |
药学 | 29篇 |
中国医学 | 1篇 |
肿瘤学 | 62篇 |
出版年
2023年 | 4篇 |
2022年 | 2篇 |
2021年 | 1篇 |
2020年 | 4篇 |
2018年 | 12篇 |
2017年 | 8篇 |
2016年 | 12篇 |
2015年 | 9篇 |
2014年 | 5篇 |
2013年 | 15篇 |
2012年 | 12篇 |
2011年 | 18篇 |
2010年 | 26篇 |
2009年 | 29篇 |
2008年 | 9篇 |
2007年 | 33篇 |
2006年 | 10篇 |
2005年 | 8篇 |
2004年 | 15篇 |
2003年 | 12篇 |
2002年 | 17篇 |
2001年 | 28篇 |
2000年 | 19篇 |
1999年 | 25篇 |
1998年 | 30篇 |
1997年 | 50篇 |
1996年 | 36篇 |
1995年 | 22篇 |
1994年 | 18篇 |
1993年 | 18篇 |
1992年 | 13篇 |
1991年 | 13篇 |
1990年 | 4篇 |
1989年 | 19篇 |
1988年 | 22篇 |
1987年 | 12篇 |
1986年 | 14篇 |
1985年 | 14篇 |
1984年 | 11篇 |
1983年 | 15篇 |
1982年 | 6篇 |
1981年 | 12篇 |
1980年 | 9篇 |
1979年 | 2篇 |
1978年 | 6篇 |
1977年 | 3篇 |
1976年 | 4篇 |
1975年 | 3篇 |
1970年 | 1篇 |
1969年 | 1篇 |
排序方式: 共有692条查询结果,搜索用时 31 毫秒
1.
2.
The role of growth factors and cytokines in the impaired healing of chronic leg ulcers remains uncertain. The aim of this study was to determine whether changes in the amount and location of cytokines and growth factors may be associated with impaired healing in chronic leg ulcers. Biopsies from leg ulcers of 21 patients and from normal skin of nine healthy volunteers were examined immunohistochemically for selected growth factors and cytokines. Greater staining intensity was found in keratinocytes at the edges of ulcers compared to normal skin, or skin adjacent to the ulcers. Staining at the ulcer edge was more intense in nonhealing ulcers for only vascular endothelial growth factor and platelet-derived growth factor, whereas staining in the adjacent skin was more intense for all factors in the nonhealing phase. For all factors staining was cytoplasmic, suggesting production in these areas. This study shows up-regulation of the production of cytokines and growth factors in keratinocytes of chronic leg ulcers that is greater when the ulcers are nonhealing. 相似文献
3.
4.
5.
6.
7.
Picotamide inhibition of excess in vitro thromboxane B2 release by colorectal mucosa in inflammatory bowel disease. 总被引:1,自引:0,他引:1
Collins CE Benson MJ Burnham WR Rampton DS 《Alimentary pharmacology & therapeutics》1996,10(3):315-320
BACKGROUND: Inflammatory bowel disease is associated with increased mucosal release of eicosanoids. Among these, thromboxane A2 has been proposed as a possible inflammatory mediator; its suppression may be a useful therapeutic option. METHODS: Using a tissue incubation technique, we compared release of immunoreactive thromboxane B2 by colonic biopsies from patients with ulcerative colitis, Crohn's disease and controls, and assessed the inhibitory effect of picotamide, a thromboxane synthesis inhibitor-receptor antagonist, which has been widely used in Italy for management of ischaemic heart and cerebrovascular disease. RESULTS: Increased amounts of thromboxane B2 were released from biopsies from patients with active ulcerative colitis (median 238 pg/20 min/mg wet weight (interquartile range 147- 325), n = 12) and active Crohn's disease (252 (174-450), 6) compared with those from patients with quiescent ulcerative colitis (95 (61- 140), 12) or Crohn's disease (105 (57-201), 13), or controls (136 (64- 206), 8). Incubation with picotamide at concentrations between 100 microM and 1 mM reduced thromboxane B2 release (IC50 890 microM). CONCLUSION: Since increased thromboxane A2 production may have pathogenetic importance, thromboxane synthesis inhibitor-receptor antagonists such as picotamide merit therapeutic trial in the management of inflammatory bowel disease. 相似文献
8.
Anderson RA; Evans LW; Irvine DS; McIntyre MA; Groome NP; Riley SC 《Human reproduction (Oxford, England)》1998,13(12):3319-3325
Follistatin is a binding protein for the activin and inhibin family of
hormones, regulating their biological activity. In the male reproductive
tract, the interaction of these factors is likely to be involved in the
regulation of the proliferation of several cell types. We have investigated
the presence of follistatin and activin A in seminal plasma using specific
immunoassays and have localized follistatin and activin/inhibin subunits in
the adult human testis, prostate and seminal vesicle to establish their
likely sources. High concentrations of immunoreactive follistatin were
present in seminal plasma in normal men (mean 97.9 ng/ml; 1.43 ng/ml in
peripheral plasma) and were similar in men with oligo/azoospermia and
following vasectomy. Follistatin immunoreactivity was localized to both
Leydig and Sertoli cells of the testis, and to epithelial cells of the
prostate gland and seminal vesicle, which are likely to be the predominant
sources of the hormone in seminal plasma. Activin A was also present in
seminal plasma in normal men but was undetectable following vasectomy, thus
deriving from the testis. Consistent with this finding, the betaA-subunit
was immunolocalized in Sertoli and Leydig cells but was not present in
seminal vesicle or prostate gland. The functional significance of the high
concentrations of follistatin secreted into seminal plasma by the prostate
gland and/or seminal vesicle is uncertain, but they may regulate the
biological activity of testis-derived activin A and inhibin B.
相似文献
9.
Biomarkers have long held out the promise that malignancies might be diagnosed early and that patients could be monitored more confidently during their clinical course to more reliably predict recurrence and the effect of therapy. Reliable tumor markers have been described for colon carcinoma, hepatomas, and other tumors, but no reliable marker has been identified to monitor the course of malignant melanoma. Recently, the plasma level of lipid-bound sialic acid (LASA-P) has been described as reflecting an alteration in the surface membrane of cancer cells. An attempt was made to correlate the LASA-P level, along with the serum level of neuron-specific enolase, a glycolytic enzyme specific to cells of neuroectoderm origin including melanocytes, with clinical disease activity with a follow-up to at least 2 years. Two hundred seventy patients had blood samples drawn at various times during their clinical course for assay of LASA-P and neuron-specific enolase. Eighty of the patients (30%) sampled developed a recurrence sometime during their clinical course, whereas another 10 patients had active disease noted at diagnosis with evaluative tumor markers. The sensitivity and specificity of neuron-specific enolase was 27% and 77%, respectively, and cannot be recommended as a marker for melanoma. LASA-P showed a sensitivity of 65%, with 55 patients recurring and having active disease with abnormally high markers and 35 patients recurring or having active disease with normal markers. Specificity of the LASA-P test was 76%. When recurrence was associated with elevated LASA-P levels, the elevated level preceded recurrence by a median of 9.3 months. LASA-P may be a useful marker to follow patients with malignant melanoma. 相似文献
10.
Dr. David H. Berger MD Barry W. Feig MD Donald Podoloff MD James Norman MD C. Wayne Cruse MD Douglas S. Reintgen MD Merrick I. Ross MD 《Annals of surgical oncology》1997,4(3):247-251
Background: If cutaneous lymphoscintigraphy (CL) is accurate in predicting the draining lymph node basins at risk from primary axial
melanomas, then regional metastases should only occur in those lymph node basins identified by CL.
Methods: This study is a retrospective review of patients undergoing CL for primary axial melanomas from June 1, 1985, until June
31, 1992. Data retrieved included age, gender, number of basins identified, location of basins identified, management of basins,
recurrence in lymphatics, development of distant disease, and long-term follow-up.
Results: A total of 181 patients underwent elective LND, and 48 patients (27%) had melanoma in the nodes within the dissected basin.
Of these 181 patients, seven developed nodal metastases as their site of first recurrence. All seven recurrences were seen
at sites dissected or at sites indicated by CL, which the primary surgeon elected not to treat initially. Of the 116 patients
observed, 16 (14%) developed lymph node metastases as their first site of recurrence. Fifteen of these 16 patients had their
site of lymph node metastases predicted by CL. In this study, CL predicted 98.6% of all lymph node metastases.
Conclusions: The high overall reliability of CL as demonstrated by long-term follow-up indicates that the information obtained by CL can
be reliably used to guide intervention. Initial evaluation of patients with high-risk cutaneous melanomas at sites with ambiguous
lymphatic drainage must include CL in order to determine the draining lymph node basins and to plan therapy.
Presented at the 47th Annual Cancer Symposium of The Society of Surgical Oncology, Houston, Texas, March 17–20, 1994. 相似文献